About Sahani Chandraratna
Form D filings for Io Therapeutics in 2023 list Sahani Chandraratna as director.
Sahani Chandraratna first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sahani Chandraratna in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sahani Chandraratna works with at each company, as listed on that company's latest Form D.
Io Therapeutics, Inc. · Form D/A, Aug 3, 2023
SL
Sharon Lew
Executive officer
VV
Vidyasagar Vuligonda
Executive officer
MS
Martin Sanders
Chief Executive Officer